Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.

The American journal of medicine - 1 Apr 2001

Davies S M, DeFor T E, McGlave P B, Miller J S, Verfaillie C M, Wagner J E, Weisdorf D J

Abstract excerpt

PURPOSE: To determine if the favorable outcomes after transplantation of matched sibling donor bone marrow in patients with chronic myelogenous leukemia can be achieved using bone marrow from an HLA-A,B/DRB1-matched unrelated donor. SUBJECTS AND METHODS: Between April 1983 and December 1997, 141 patients with chronic myelogenous leukemia in its first chronic phase received a bone marrow transplant from a matched...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Transplantation
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-A Antigens

Share to HLA-B Antigens

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Proportional Hazards Models

Share to Tissue Donors

Share to Transplantation Conditioning

Source

Identifiers

PMID: 11286947
DOI: 10.1016/s0002-9343(01)00629-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.PMID 11286947Read ↗

Matched and mismatched unrelated donor transplantation: is the outcome the same as for matched sibling donor transplantation?Semantic proximity Read ↗

Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent EraSemantic proximity Read ↗

Long-Term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic MalignancySemantic proximity Read ↗

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosisSemantic proximity Read ↗

Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status.Semantic proximity Read ↗

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.Semantic proximity Read ↗

Effect of Graft Source on Unrelated Donor Hemopoietic Stem Cell Transplantation in Adults with Acute Myeloid Leukemia after Reduced-Intensity or Nonmyeloablative Conditioning: A Study from the Société Francaise de Greffe de Moelle et de Thérapie CellulaireSemantic proximity Read ↗

Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemiaSemantic proximity Read ↗

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemiaSemantic proximity Read ↗

Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center StudySemantic proximity Read ↗

Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic LeukemiaSemantic proximity Read ↗

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.